Calif. should not rush to pass biosimilars bill

10/10/2013 | San Francisco Chronicle (free content)

California Gov. Jerry Brown should veto a state law that would limit the use of biosimilars because it is more about protecting profits rather than patients, according to this editorial. The state should not rush to pass SB 598 and wait for the FDA to do its work as standards for safely substituting biosimilars could be laid out early in 2014.

View Full Article in:

San Francisco Chronicle (free content)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN